Preclinical presentation highlights key, modality specific, pharmacological differentiations of VG-3927 - - First presentation of topline ...

Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the publication of research in JAMA Neurology, which informs a possible therapeutic strategy to treat a rare ...

Gut microbial dysbiosis has been implicated in both GI and neuopsychiatric symptoms observed in ASD through various ...

The benefits of weight training are many: it promotes gains in strength and muscle mass, reduces body fat, and contributes to ...

NeuroNOS, a subsidiary of Beyond Air (XAIR), announces the publication of breakthrough research by its Chief Scientific Officer, Prof. Haitham ...

Budgeted spending for NIH BRAIN Initiative has plunged by more than half, from $680 million in 2023 to $320 million this year ...

Neurons communicate with each other by passing millisecond-long signals across tiny junctions called synapses. Experiences ...

It is estimated that more than 22 million children and adults in the US have ADHD. The condition is thought to be caused by a ...

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S.

A European regulatory committee has rejected Eli Lilly's U.S.-approved Alzheimer's disease treatment over potentially ...

New Brunswick health officials will begin analyzing hundreds of cases involving a mystery brain disease that has baffled ...

Thursday, Mar 06, 2025 • Katherine Egan Bennett : Researchers from The University of Texas at Arlington and the University of California–San Francisco have used a new brain-mapping technique to ...